5,8-dimethoxy-2,3-dimethylquinoxalin-6-amine
- CAS NO.:56393-25-0
- Empirical Formula: C12H15N3O2
- Molecular Weight: 233.27
- MDL number: MFCD01684974
- Update Date: 2023-07-14 17:46:20

Properties of 5,8-dimethoxy-2,3-dimethylquinoxalin-6-amine
Melting point: | 189-190 °C(Solv: benzene (71-43-2)) |
Boiling point: | 409.5±40.0 °C(Predicted) |
Density | 1.209±0.06 g/cm3(Predicted) |
pka | 2.66±0.48(Predicted) |
Safety information for 5,8-dimethoxy-2,3-dimethylquinoxalin-6-amine
Computed Descriptors for 5,8-dimethoxy-2,3-dimethylquinoxalin-6-amine
5,8-dimethoxy-2,3-dimethylquinoxalin-6-amine manufacturer
GRK RESEARCH LABORATORIES PVT LTD
2Y
Phone:+91-7093001765
Whatsapp: +91- 7093001765
product: 6-AMINO-5, 8-DIMETHOXY-2,3-DIMETHYLQUINOXALINE 98%+
New Products
1-Boc-4-cyanopiperidine tert-Butyl carbazate 1-(TERT-BUTOXYCARBONYL)-2-PYRROLIDINONE TETRABUTYLAMMONIUM CYANIDE TETRAHYDRO-2H-PYRAN-3-OL 3-Pyridineacrylic acid Nickel(II) perchlorate hexahydrate, 98% 4-Bromophenylacetonitrile, 95% 3-Bromo-4-fluoroaniline, 97% Sodium tetraborate decahydrate, 98% Palladium(II) acetate, trimer, Pd 99% 4-Bromo-2-chlorotoluene, 97% Tadalafil Clopidogrel bisulfate Sitagliptin Phosphate Monohydrate Cabergoline Fexofinadine HCl Etoricoxib 4-Amino Acetophenone 2-Chloro Acetophenone Amlodipine Base 2,3,5-Triiodobenzoic Acid Pyrrolidine Diiodo PentoxideYou may like
-
6-AMINO-5, 8-DIMETHOXY-2,3-DIMETHYLQUINOXALINE 98%+View Details
56393 - 2 5 - 0 -
366789-02-8 Riveroxaban 98%View Details
366789-02-8 -
Phenylephrine HCl 61-76-7 98%View Details
61-76-7 -
Carvedilol 98%View Details
72956-09-3 -
Abiretorone 154229-18-2 98%View Details
154229-18-2 -
73590-58-6 Omeprazole 98%View Details
73590-58-6 -
201530-41-8 Deferasirox 98%View Details
201530-41-8 -
Sertraline HCl 98%View Details
79559-97-0
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.